Zealand Pharma A/S
ZEAL
Ранг среди акций
#5528
Zealand Pharma A/S is a Danish biotechnology firm dedicated to the... Zealand Pharma A/S is a Danish biotechnology firm dedicated to the identification, progression, and market introduction of peptide-based therapeutics. The company concentrates its efforts on treatments for gastrointestinal and metabolic ailments, as well as other specialized conditions where current medical options are insufficient. Its commercialized product, Dasiglucagon, is an injectable solution provided in a pre-filled syringe or autoinjector, used to address severe hypoglycemia. Furthermore, Zealand Pharma is actively developing Dasiglucagon for inclusion in bi-hormone artificial pancreas systems that integrate both insulin and dasiglucagon. The compound Dasiglucagon is also undergoing late-stage (Phase III) clinical trials for congenital hyperinsulinism. Another significant asset in its development pipeline is glepaglutide, a long-acting GLP-2 analog, which is likewise in Phase III clinical studies for treating short bowel syndrome. Founded in 1998 and headquartered in Copenhagen, Denmark, Zealand Pharma A/S maintains strategic alliances with a range of partners, including Sanofi-Aventis Deutschland GmbH, Boehringer Ingelheim International GmbH, Alexion Pharmaceuticals, Inc., and Beta Bionics, Inc.
Цена акции
$35.14
Рыночная капитализация
$2.44B
Изменение (1 день)
-1.95%
Изменение (1 год)
-50.93%
Страна
DK
Торговля Zealand Pharma A/S (ZEAL)
Категория
Healthcare
Рыночная капитализация Zealand Pharma A/S(ZEAL)
Рыночная капитализация: $2.44B
По состоянию на October 2026 рыночная капитализация Zealand Pharma A/S составляет $2.44B. Согласно нашим данным, Zealand Pharma A/S занимает 5528th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Zealand Pharma A/S с 2013 по 2026
ZEAL по сравнению с пятеркой самых популярных stocks
